Search for company

Laboratorios Andromaco S.A. (Chile)

Quote Chart
Quote Summary
Last Price 310.00
Volume 1,763,000
Turnover 550,056,000
Index    CHILE 65
Market Bolsa Electrónica de Valores
Market Cap Market Cap 186,368,539
52 Week High 310.00
52 Week Low 229.50
P/E -404
EPS -0
Dividend Yield 0 (16 de octubre de 2012)
Bookvalue 31,149,343
Enterprise Value 223,498,490
Quote updated on October 11, 2013
Note: data in CLP Thousands.
Select Items to chart them. 2014 Q1
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 115,241,080
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Consolidated
Source: Superintendencia de Valores y Seguros, EMIS Company Database.
Company Description

Marketing and production of drugs of excellent quality and efficiency. The company represents important international pharmaceuticals firms, through which it incorporates exclusive and innovative products to its offer, for disease prevention and treatment. In addition, Andrómaco plays an active role contributing to generate pharmaceutical knowledge trough the research and development of vanguard products. The company is formed by Laboratorios Andrómaco S.A., Laboratorios Silesia S.A., ABL Pharma,…

Main Products


Contact Information

Blvd. Quilin 5273 Peñalolen
Santiago; Metropolitana; Map
Tel: +56 2 594 8000

Full name: Laboratorios Andromaco S.A.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
CL-RUT: 924480009
ISIN Code: CL0000000464
Incorporation Date: 30-Aug-00

Basic Information
Total Employees:
Outstanding Shares:
: ()
Financial Auditors:
Key Executives
President of the Board Directors
Ownership Details
Inversiones Gruchi Limitada
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Chile

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.